Rebecca McCullough
Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Diseases, Alcoholic | 16 | 2022 | 95 | 3.940 |
Why?
| | Ethanol | 23 | 2025 | 643 | 3.820 |
Why?
| | Chemical and Drug Induced Liver Injury | 2 | 2024 | 146 | 1.460 |
Why?
| | Hepatocytes | 6 | 2022 | 219 | 1.280 |
Why?
| | Liver | 16 | 2025 | 1869 | 1.270 |
Why?
| | Receptor, Anaphylatoxin C5a | 2 | 2018 | 29 | 1.050 |
Why?
| | Carbon Tetrachloride | 2 | 2025 | 14 | 0.940 |
Why?
| | Wnt-5a Protein | 1 | 2024 | 25 | 0.880 |
Why?
| | Wnt3A Protein | 1 | 2024 | 11 | 0.880 |
Why?
| | Hepatic Stellate Cells | 1 | 2024 | 15 | 0.880 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2025 | 165 | 0.820 |
Why?
| | Binge Drinking | 1 | 2023 | 46 | 0.790 |
Why?
| | Mice, Inbred C57BL | 21 | 2026 | 6055 | 0.790 |
Why?
| | Inflammation | 9 | 2025 | 2882 | 0.750 |
Why?
| | Aldehydes | 6 | 2014 | 146 | 0.740 |
Why?
| | Alcoholism | 4 | 2024 | 838 | 0.720 |
Why?
| | Neurodegenerative Diseases | 1 | 2023 | 143 | 0.710 |
Why?
| | NF-kappa B | 1 | 2025 | 685 | 0.680 |
Why?
| | Fatty Acids | 3 | 2022 | 453 | 0.660 |
Why?
| | Mice | 28 | 2026 | 18414 | 0.630 |
Why?
| | Alcohol Drinking | 5 | 2026 | 853 | 0.590 |
Why?
| | Nanoparticles | 1 | 2025 | 504 | 0.580 |
Why?
| | Aging | 3 | 2025 | 1955 | 0.540 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 441 | 0.540 |
Why?
| | PTEN Phosphohydrolase | 4 | 2016 | 165 | 0.540 |
Why?
| | Protein Carbonylation | 5 | 2016 | 59 | 0.500 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2018 | 219 | 0.490 |
Why?
| | Animals | 33 | 2026 | 38066 | 0.490 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2016 | 71 | 0.480 |
Why?
| | Diet, High-Fat | 4 | 2026 | 261 | 0.450 |
Why?
| | Myeloid Cells | 1 | 2016 | 148 | 0.450 |
Why?
| | Adipose Tissue | 1 | 2018 | 654 | 0.410 |
Why?
| | Fatty Acid-Binding Proteins | 3 | 2013 | 74 | 0.350 |
Why?
| | Hepatitis, Alcoholic | 2 | 2021 | 15 | 0.350 |
Why?
| | Fatty Liver | 3 | 2014 | 249 | 0.340 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2016 | 441 | 0.340 |
Why?
| | Fatty Liver, Alcoholic | 2 | 2016 | 14 | 0.320 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2014 | 195 | 0.270 |
Why?
| | Disease Models, Animal | 9 | 2026 | 4538 | 0.270 |
Why?
| | Lipid Peroxidation | 3 | 2014 | 162 | 0.260 |
Why?
| | Myelopoiesis | 1 | 2026 | 10 | 0.240 |
Why?
| | Osteoclasts | 1 | 2026 | 56 | 0.240 |
Why?
| | Public Opinion | 2 | 2023 | 60 | 0.240 |
Why?
| | Liver Cirrhosis | 2 | 2025 | 285 | 0.230 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2020 | 266 | 0.230 |
Why?
| | Proteins | 2 | 2012 | 1023 | 0.230 |
Why?
| | Gastrointestinal Microbiome | 2 | 2025 | 736 | 0.220 |
Why?
| | Immunologic Surveillance | 1 | 2025 | 26 | 0.220 |
Why?
| | Apoptosis | 4 | 2018 | 2519 | 0.220 |
Why?
| | Cell Transdifferentiation | 1 | 2024 | 31 | 0.220 |
Why?
| | Mice, Knockout | 5 | 2021 | 3112 | 0.220 |
Why?
| | Liver Regeneration | 1 | 2024 | 47 | 0.220 |
Why?
| | Metabolic Diseases | 1 | 2026 | 116 | 0.220 |
Why?
| | Immunity | 1 | 2025 | 139 | 0.210 |
Why?
| | Osteogenesis | 1 | 2026 | 204 | 0.210 |
Why?
| | Lactoylglutathione Lyase | 1 | 2024 | 19 | 0.210 |
Why?
| | Inflammasomes | 1 | 2025 | 146 | 0.200 |
Why?
| | Ethyl Ethers | 1 | 2022 | 5 | 0.190 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2023 | 30 | 0.190 |
Why?
| | Microglia | 1 | 2025 | 262 | 0.190 |
Why?
| | Wnt Signaling Pathway | 1 | 2024 | 213 | 0.190 |
Why?
| | beta Catenin | 1 | 2024 | 256 | 0.190 |
Why?
| | Immune Tolerance | 1 | 2025 | 384 | 0.190 |
Why?
| | Glycoproteins | 2 | 2021 | 356 | 0.180 |
Why?
| | Central Nervous System Depressants | 2 | 2018 | 89 | 0.180 |
Why?
| | Complement Factor D | 2 | 2020 | 28 | 0.180 |
Why?
| | Proteomics | 4 | 2021 | 1162 | 0.180 |
Why?
| | Cytokines | 3 | 2018 | 2099 | 0.180 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2025 | 365 | 0.170 |
Why?
| | Oxidative Stress | 6 | 2016 | 1376 | 0.170 |
Why?
| | Mitochondria, Liver | 1 | 2011 | 70 | 0.170 |
Why?
| | Protein Phosphatase 2 | 1 | 2021 | 42 | 0.170 |
Why?
| | Fluorocarbons | 1 | 2023 | 141 | 0.170 |
Why?
| | Endoplasmic Reticulum | 2 | 2014 | 263 | 0.170 |
Why?
| | Sirtuin 3 | 1 | 2011 | 61 | 0.160 |
Why?
| | Multigene Family | 1 | 2011 | 205 | 0.160 |
Why?
| | Extracellular Matrix | 1 | 2024 | 559 | 0.160 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 138 | 0.160 |
Why?
| | Lipoproteins, LDL | 1 | 2020 | 112 | 0.160 |
Why?
| | Lymphatic Vessels | 1 | 2020 | 62 | 0.160 |
Why?
| | Sarcopenia | 1 | 2021 | 82 | 0.150 |
Why?
| | Kupffer Cells | 2 | 2017 | 49 | 0.150 |
Why?
| | Female | 12 | 2025 | 77403 | 0.150 |
Why?
| | Hippocampus | 1 | 2025 | 950 | 0.150 |
Why?
| | Intestinal Mucosa | 2 | 2025 | 665 | 0.150 |
Why?
| | Sulfhydryl Compounds | 1 | 2011 | 190 | 0.150 |
Why?
| | Anaphylatoxins | 1 | 2018 | 1 | 0.150 |
Why?
| | Models, Molecular | 4 | 2014 | 1624 | 0.140 |
Why?
| | Tandem Mass Spectrometry | 4 | 2021 | 566 | 0.140 |
Why?
| | Endothelial Cells | 1 | 2025 | 847 | 0.140 |
Why?
| | Premature Birth | 1 | 2023 | 375 | 0.140 |
Why?
| | Blotting, Western | 2 | 2016 | 1223 | 0.140 |
Why?
| | Adipokines | 1 | 2018 | 53 | 0.140 |
Why?
| | Liver Neoplasms | 1 | 2025 | 757 | 0.140 |
Why?
| | Male | 20 | 2026 | 71658 | 0.140 |
Why?
| | Histones | 1 | 2024 | 669 | 0.140 |
Why?
| | Primary Cell Culture | 1 | 2018 | 171 | 0.140 |
Why?
| | Gastrointestinal Tract | 1 | 2020 | 204 | 0.140 |
Why?
| | Protective Agents | 1 | 2018 | 41 | 0.140 |
Why?
| | Rats | 4 | 2017 | 5610 | 0.130 |
Why?
| | Complement Pathway, Alternative | 1 | 2018 | 123 | 0.130 |
Why?
| | Humans | 23 | 2025 | 143807 | 0.130 |
Why?
| | Evolution, Molecular | 1 | 2011 | 507 | 0.130 |
Why?
| | Phosphorylation | 2 | 2016 | 1781 | 0.130 |
Why?
| | Adipocytes | 1 | 2018 | 222 | 0.130 |
Why?
| | Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2016 | 14 | 0.120 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2016 | 23 | 0.120 |
Why?
| | Immune System | 1 | 2018 | 183 | 0.120 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 11 | 0.120 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1736 | 0.120 |
Why?
| | Complement C1q | 1 | 2016 | 33 | 0.120 |
Why?
| | Extracellular Vesicles | 1 | 2018 | 162 | 0.120 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2023 | 680 | 0.120 |
Why?
| | Amino Acid Sequence | 4 | 2014 | 2167 | 0.120 |
Why?
| | Toll-Like Receptor 4 | 1 | 2017 | 276 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 346 | 0.110 |
Why?
| | Rats, Wistar | 1 | 2016 | 454 | 0.110 |
Why?
| | Immunoglobulin M | 1 | 2016 | 288 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 475 | 0.110 |
Why?
| | Heat-Shock Proteins | 1 | 2014 | 140 | 0.100 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2014 | 124 | 0.100 |
Why?
| | Adenosine Triphosphatases | 1 | 2014 | 160 | 0.100 |
Why?
| | Complement Activation | 1 | 2016 | 413 | 0.100 |
Why?
| | Lipopolysaccharides | 1 | 2016 | 861 | 0.090 |
Why?
| | Molecular Sequence Data | 3 | 2011 | 2944 | 0.090 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2014 | 141 | 0.090 |
Why?
| | MicroRNAs | 1 | 2017 | 698 | 0.080 |
Why?
| | Aortic Valve Stenosis | 1 | 2014 | 246 | 0.080 |
Why?
| | Dietary Fats | 1 | 2013 | 304 | 0.080 |
Why?
| | Enzyme Activation | 2 | 2013 | 790 | 0.080 |
Why?
| | Gene Expression Regulation | 3 | 2017 | 2621 | 0.080 |
Why?
| | Chromatography, Liquid | 2 | 2013 | 453 | 0.080 |
Why?
| | Protein Conformation | 1 | 2012 | 941 | 0.070 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 2 | 2012 | 111 | 0.070 |
Why?
| | Immunoprecipitation | 2 | 2021 | 153 | 0.060 |
Why?
| | Homeostasis | 2 | 2021 | 641 | 0.060 |
Why?
| | DNA Primers | 2 | 2012 | 518 | 0.060 |
Why?
| | Protein Structure, Tertiary | 2 | 2014 | 863 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2011 | 2531 | 0.060 |
Why?
| | Biomarkers | 3 | 2021 | 4242 | 0.060 |
Why?
| | Diethylnitrosamine | 1 | 2025 | 7 | 0.060 |
Why?
| | Signal Transduction | 4 | 2017 | 5220 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2023 | 4183 | 0.050 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2014 | 50 | 0.050 |
Why?
| | Hep G2 Cells | 1 | 2014 | 74 | 0.050 |
Why?
| | Alanine Transaminase | 2 | 2016 | 154 | 0.050 |
Why?
| | Hawaii | 1 | 2023 | 41 | 0.050 |
Why?
| | Macrophages | 2 | 2024 | 1507 | 0.050 |
Why?
| | Dehydroepiandrosterone | 1 | 2023 | 51 | 0.050 |
Why?
| | Hematopoietic Stem Cells | 1 | 2026 | 417 | 0.050 |
Why?
| | Models, Chemical | 1 | 2014 | 273 | 0.050 |
Why?
| | Thiobarbituric Acid Reactive Substances | 1 | 2012 | 30 | 0.050 |
Why?
| | Heme | 1 | 2023 | 84 | 0.050 |
Why?
| | Malondialdehyde | 1 | 2012 | 29 | 0.050 |
Why?
| | Acrolein | 1 | 2012 | 22 | 0.050 |
Why?
| | Triglycerides | 2 | 2016 | 517 | 0.050 |
Why?
| | Lactic Acid | 1 | 2024 | 308 | 0.050 |
Why?
| | Cytochrome P-450 CYP3A | 1 | 2023 | 90 | 0.050 |
Why?
| | Tretinoin | 1 | 2023 | 124 | 0.040 |
Why?
| | Glycolysis | 1 | 2024 | 335 | 0.040 |
Why?
| | Eye Proteins | 1 | 2021 | 93 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 590 | 0.040 |
Why?
| | Complement C2 | 1 | 2020 | 7 | 0.040 |
Why?
| | Microsomes, Liver | 1 | 2011 | 83 | 0.040 |
Why?
| | Complement C5 | 1 | 2020 | 34 | 0.040 |
Why?
| | Complement C4 | 1 | 2020 | 26 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2025 | 1143 | 0.040 |
Why?
| | Intercellular Junctions | 1 | 2020 | 38 | 0.040 |
Why?
| | NAD | 1 | 2011 | 78 | 0.040 |
Why?
| | Myoblasts | 1 | 2021 | 84 | 0.040 |
Why?
| | Glycosylation | 1 | 2011 | 173 | 0.040 |
Why?
| | Proteostasis | 1 | 2020 | 27 | 0.040 |
Why?
| | Sequence Alignment | 1 | 2011 | 367 | 0.040 |
Why?
| | Acetylation | 1 | 2011 | 249 | 0.040 |
Why?
| | Iron | 1 | 2023 | 346 | 0.040 |
Why?
| | Permeability | 1 | 2020 | 169 | 0.040 |
Why?
| | Boston | 1 | 2020 | 92 | 0.040 |
Why?
| | Complement Factor B | 1 | 2020 | 107 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2011 | 326 | 0.040 |
Why?
| | Organ Specificity | 1 | 2020 | 311 | 0.040 |
Why?
| | Pregnancy | 2 | 2023 | 7164 | 0.040 |
Why?
| | Complement C3 | 1 | 2020 | 190 | 0.040 |
Why?
| | Chromatin | 1 | 2024 | 553 | 0.040 |
Why?
| | Species Specificity | 1 | 2011 | 577 | 0.040 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2011 | 177 | 0.040 |
Why?
| | Birth Weight | 1 | 2023 | 521 | 0.040 |
Why?
| | Water | 1 | 2023 | 471 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2021 | 498 | 0.040 |
Why?
| | Drosophila melanogaster | 1 | 2011 | 236 | 0.040 |
Why?
| | Congresses as Topic | 1 | 2020 | 228 | 0.040 |
Why?
| | Genome, Human | 1 | 2011 | 429 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 928 | 0.040 |
Why?
| | Cell Movement | 1 | 2023 | 973 | 0.030 |
Why?
| | Tumor Suppressor Proteins | 1 | 2020 | 330 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1062 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2011 | 1372 | 0.030 |
Why?
| | Complement System Proteins | 1 | 2020 | 313 | 0.030 |
Why?
| | Base Sequence | 1 | 2011 | 2200 | 0.030 |
Why?
| | Caenorhabditis elegans | 1 | 2011 | 330 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 686 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 355 | 0.030 |
Why?
| | Protein Binding | 2 | 2014 | 2265 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 523 | 0.030 |
Why?
| | Complement C1 Inactivator Proteins | 1 | 2016 | 6 | 0.030 |
Why?
| | Complement C1 Inhibitor Protein | 1 | 2016 | 11 | 0.030 |
Why?
| | Endothelium, Vascular | 1 | 2023 | 962 | 0.030 |
Why?
| | Lipogenesis | 1 | 2016 | 65 | 0.030 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 97 | 0.030 |
Why?
| | Hyaluronic Acid | 1 | 2017 | 229 | 0.030 |
Why?
| | Solubility | 1 | 2016 | 239 | 0.030 |
Why?
| | Random Allocation | 1 | 2016 | 370 | 0.030 |
Why?
| | Cytochrome P-450 CYP4A | 1 | 2014 | 4 | 0.030 |
Why?
| | Cell Death | 1 | 2016 | 394 | 0.030 |
Why?
| | CD36 Antigens | 1 | 2014 | 32 | 0.030 |
Why?
| | Glutathione | 1 | 2016 | 373 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 59 | 0.030 |
Why?
| | Echocardiography, Transesophageal | 1 | 2014 | 131 | 0.020 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2013 | 32 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 24 | 0.020 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 56 | 0.020 |
Why?
| | Age Factors | 1 | 2020 | 3330 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3633 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3615 | 0.020 |
Why?
| | Protein Folding | 1 | 2014 | 277 | 0.020 |
Why?
| | Anilino Naphthalenesulfonates | 1 | 2012 | 10 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2017 | 1228 | 0.020 |
Why?
| | Coronary Artery Bypass | 1 | 2014 | 252 | 0.020 |
Why?
| | Ubiquitination | 1 | 2012 | 108 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 4162 | 0.020 |
Why?
| | Organ Size | 1 | 2013 | 481 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2018 | 861 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2012 | 538 | 0.020 |
Why?
| | Adiponectin | 1 | 2013 | 244 | 0.020 |
Why?
| | Cholesterol | 1 | 2013 | 404 | 0.020 |
Why?
| | Patient Selection | 1 | 2014 | 692 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 994 | 0.020 |
Why?
| | Computer Simulation | 1 | 2014 | 1028 | 0.020 |
Why?
| | Hospital Mortality | 1 | 2014 | 962 | 0.020 |
Why?
| | Survival Rate | 1 | 2014 | 2008 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2012 | 741 | 0.020 |
Why?
| | Lipids | 1 | 2013 | 704 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2013 | 759 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2194 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2013 | 2854 | 0.010 |
Why?
| | Transcription Factors | 1 | 2013 | 1754 | 0.010 |
Why?
| | Risk Assessment | 1 | 2014 | 3582 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2423 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2014 | 8077 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2014 | 2902 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2014 | 11389 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 35398 | 0.010 |
Why?
| | Adult | 1 | 2020 | 40083 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 16781 | 0.010 |
Why?
|
|
McCullough's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|